Joshua Muia: Our Latest Review on the Proatherogenic Metalloprotease ADAMTS7
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Thrilled to share our newly published review on the proatherogenic metalloprotease ADAMTS7!
Proud of the incredible effort by trainees in my lab, working together with medical students and postdoctoral fellows across Oklahoma State University Center for Health Sciences, National Eye Institute (NIH), Georgetown University Medical Center, and Versiti Blood Research Institute.”
Title: The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7
Authors: Shiwali Goyal, James Muniu, Mohd Akbar Bhat, Eli Oldham, Derrick Pruitt, Luis Frias Perez, Frida Miranda, Joshua Muia
Read the Full Article on Open Biology
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 17:30Veronica Sanchez: Do You Live with Pain after a Stroke?
-
May 22, 2026, 17:25Maxime Dely: A Simple but Powerful Indicator of Platelet Quality
-
May 22, 2026, 17:24Jim Hoffman: A New Approach to Balancing Host Defense and Tissue Protection
-
May 22, 2026, 17:22Lucia Rugeri: Advancing Multidisciplinary Care for Heavy Menstrual Bleeding in Women with Bleeding Disorders
-
May 22, 2026, 17:20Nour Al-Mozain: Optimizing PBSC Collection Through Real-Time CD34+ Monitoring
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque